product summary
Loading...
company name :
R&D Systems
product type :
antibody
product name :
MIF Alexa Fluor Plus 405-conjugated Antibody
catalog :
AF-289-PBAFP405
quantity :
100 ug
price :
609 USD
clonality :
polyclonal
host :
domestic goat
conjugate :
nonconjugated
reactivity :
human, mouse, rat
application :
western blot
more info or order :
product information
brand :
R&D Systems
master code :
AF-289-PBAFP405
SKU :
AF-289-PBAFP405
product name :
MIF Alexa Fluor Plus 405-conjugated Antibody
sizes available :
100 ug
description :
The Human/Mouse/Rat MIF Alexa Fluor Plus 405-conjugated Antibody from AF-289-PBAFP405 is a 0.065 antibody to . This antibody reacts with human,mouse,rat.
target :
MIF
category :
Primary Antibodies
buffer :
Supplied 0.2 mg/mL in a saline solution containing BSA and Sodium Azide.
clonality :
Polyclonal
conjugate :
Alexa Fluor Plus 405
host :
Goat
immunogen :
E. coli -derived recombinant human MIF
isotype :
IgG
species :
Human,Mouse,Rat
specificity :
Detects human, mouse, and rat MIF in Western blots.
applications :
Western Blot,Intracellular Staining by Flow Cytometry,CyTOF-ready
USD :
609 USD
alt names :
EC 5.3.2.1, EC 5.3.3.12, GIFmacrophage migration inhibitory factor, GLIF, Glycosylation-inhibiting factor, L-dopachrome isomerase, L-dopachrome tautomerase, macrophage migration inhibitory factor (glycosylation-inhibiting factor), MMIF, Phenylpyruvate tautomerase
storage :
Protect from light. Do not freeze. 12 months from date of receipt, 2 to 8 °C as supplied
more info or order :
company information

R&D Systems
614 McKinley Place N.E.
Minneapolis, MN 55413
Minneapolis, MN 55413
info@RnDSystems.com
https://www.rndsystems.com800 343-7475
headquarters: USA
R&D Systems develops and manufactures high-quality proteins and serves as a world leader in immunoassays. R&D Systems also produces quality antibodies, antibody arrays, stem cell and cell culture products, and cell selection and detection products, serving the life science and diagnostics industry.
related products
browse more products
questions and comments
